Maat Pharma SA
PAR:MAAT
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4.92
9.6
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Maat Pharma SA
Accrued Liabilities
Maat Pharma SA
Accrued Liabilities Peer Comparison
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Maat Pharma SA
PAR:MAAT
|
Accrued Liabilities
€1.3m
|
CAGR 3-Years
37%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
Valneva SE
PAR:VLA
|
Accrued Liabilities
€41.5m
|
CAGR 3-Years
50%
|
CAGR 5-Years
36%
|
CAGR 10-Years
26%
|
|
Nanobiotix SA
PAR:NANO
|
Accrued Liabilities
€7.4m
|
CAGR 3-Years
4%
|
CAGR 5-Years
110%
|
CAGR 10-Years
23%
|
|
Innate Pharma SA
PAR:IPH
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Genfit SA
NASDAQ:GNFT
|
Accrued Liabilities
€4.2m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
Eurobio Scientific SA
PAR:ALERS
|
Accrued Liabilities
€6.1m
|
CAGR 3-Years
5%
|
CAGR 5-Years
20%
|
CAGR 10-Years
6%
|
See Also
What is Maat Pharma SA's Accrued Liabilities?
Accrued Liabilities
1.3m
EUR
Based on the financial report for Dec 31, 2023, Maat Pharma SA's Accrued Liabilities amounts to 1.3m EUR.
What is Maat Pharma SA's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
42%
Over the last year, the Accrued Liabilities growth was 5%. The average annual Accrued Liabilities growth rates for Maat Pharma SA have been 37% over the past three years , 42% over the past five years .